Brief: Kuros To Receive Potentially $166.5 Million In Future Revenues Under Royalty Purchase Agreement

Kuros Biosciences AG

15/07/2021 06:07

July 15 (Reuters) - Kuros Biosciences AG  KURN.S :
    * KUROS TO RECEIVE $7 MILLION UP FRONT AND POTENTIALLY
$166.5
MILLION IN FUTURE REVENUES UNDER A ROYALTY PURCHASE AGREEMENT
WITH XOMA RELATED TO KUROS'S LICENSE AGREEMENT WITH CHECKMATE
PHARMACEUTICALS
    * RETAINS POTENTIAL TO RECEIVE UP TO $24 MILLION IN
PRE-COMMERCIAL
MILESTONES FROM CHECKMATE, AND IS ELIGIBLE TO RECEIVE UP TO
$142.5 MILLION IN SALES MILESTONES FROM XOMA.
    * HAS ENTERED INTO A ROYALTY PURCHASE AGREEMENT WITH XOMA
CORPORATION
    * MILESTONE PAYMENTS TOGETHER WITH PAYMENT FROM ROYALTY
PURCHASE
AGREEMENT ANNOUNCED TODAY AMOUNT TO $13 MILLION IN REVENUE TO
KUROS IN 2021.

Source text for Eikon:  ID:nEQ3hk4tqa 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))